CrossrefInfokarte
The dual role of SGLT2 inhibitors: glycemic control and cardioprotection in anthracycline-treated cancer patients
International Journal of Physiology, Pathophysiology and Pharmacology · 2025
DOI: 10.62347/gaxz3059 ↗Abstract
Kein Abstract verfügbar.
EUVIMED